Zoeken | SPORTIVO Network

rishika_2003 toegevoegd een audio Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!
Kumud toegevoegd een audio Health
2026-03-24 11:31:26

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Reacties 0 aandelen 437 Views 0 voorbeeld

Please log in to like, share and comment!
rishika_2003 toegevoegd een audio Health
2026-03-16 06:30:43

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Reacties 0 aandelen 919 Views 0 voorbeeld

Please log in to like, share and comment!
naznins407 toegevoegd een audio Health
2026-03-04 08:38:25

Market Outlook 2025–2031: Future of Sarcoma Drug Development
Orphan drug designation is supporting market expansion.Regulatory incentives encourage rare cancer drug development.Faster approvals enhance product commercialization opportunities The Sarcoma Drugs Market is projected to witness steady growth, registering a CAGR of 7.9% from 2025 to 2031. The market size is expected to expand from US$ XX million in 2024 to US$ XX million by 2031, driven by...

1

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!
naznins407 toegevoegd een audio Health
2026-03-04 13:05:45

Rising Oncology Advances Boost Bladder Cancer Market Value
Precision medicine is revolutionizing bladder cancer management strategies.Personalized treatment plans based on genetic profiling improve effectiveness.This trend is expanding opportunities within both therapeutics and diagnostics segments. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!
naznins407 toegevoegd een audio Health
2026-03-05 05:15:07

Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer Therapies
The rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...

0 Reacties 0 aandelen 3K Views 0 voorbeeld

Please log in to like, share and comment!